Axonify Receives Gold and Silver in Brandon Hall Group's 2024 Excellence in Technology Awards
Recognized with Gold Award for "Best Advance in Learning Management Measurement/Business Impact Tools," Silver Award for "Best Advance in a Generative AI Solution" WATERLOO, ON, Jan. 7, 2025 /PRNewswire/ -- Axonify, a global leader in frontline...
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026. Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding...
Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
In Hong Kong, the 20-valent Pneumococcal Conjugate Vaccine (PCV20) that offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine – helping to fight against 20 serotypes leading to most of the invasive pneumococcal...
24 Exchange Receives SEC Approval of its New National Securities Exchange, "24X National Exchange"
24X National Exchange Plans to be the First Exchange to Offer U.S. Equities Trading 23 Hours-Per-Day on Weekdays STAMFORD, Conn., Nov. 28, 2024 /PRNewswire/ -- 24 Exchange announced today that it has received approval from the U.S. Securities and...